Semaglutide: A Promising Ally Against Alzheimer’s?
In a groundbreaking study, researchers at Case Western Reserve School of Medicine have identified a potential new benefit of semaglutide, a widely used diabetes and weight-loss drug. According to their findings, semaglutide may significantly reduce the risk of Alzheimer’s disease in individuals with type 2 diabetes (T2D), outperforming seven other anti-diabetic medications.
Alzheimer’s disease, a devastating brain disorder that erodes memory and cognitive abilities, affects nearly 7 million Americans aged 65 and older, as reported by the Alzheimer’s Association. Alarmingly, it claims more lives annually than breast and prostate cancer combined.
Published in Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association, the study suggests that T2D patients taking semaglutide had a markedly lower risk of developing Alzheimer’s disease. This trend was consistent across various subgroups, regardless of obesity status, gender, or age.
Semaglutide, a glucagon-like peptide receptor (GLP-1R) agonist, is the active ingredient in popular medications like Wegovy and Ozempic. It works by reducing hunger and regulating blood sugar levels in T2D patients.
Under the leadership of Rong Xu, a professor of biomedical informatics, the research team analyzed three years of electronic health records from nearly one million U.S. patients with T2D. Their statistical approach, which mimicked a randomized clinical trial, revealed that patients prescribed semaglutide had a significantly lower risk of Alzheimer’s compared to those on other anti-diabetic medications.
According to the CDC, Alzheimer’s disease results in approximately 120,000 deaths annually, ranking as the seventh-leading cause of death in the United States.
“This new study provides real-world evidence for semaglutide’s potential impact on Alzheimer’s disease,” Xu stated. “While preclinical research has hinted at its protective effects against neurodegeneration and neuroinflammation, our findings suggest the need for further exploration through randomized clinical trials.”
Despite these promising results, the study’s limitations prevent researchers from drawing definitive causal conclusions. Xu emphasized the importance of continued research into semaglutide’s potential as a treatment for this debilitating condition, encouraging further investigation into alternative drugs.
For more information, please contact Patty Zamora at [email protected].
More Articles
Getting licensed or staying ahead in your career can be a journey—but it doesn’t have to be overwhelming. Grab your favorite coffee or tea, take a moment to relax, and browse through our articles. Whether you’re just starting out or renewing your expertise, we’ve got tips, insights, and advice to keep you moving forward. Here’s to your success—one sip and one step at a time!
After a turbulent 2025 marked by stalled construction, tight capital, and economic uncertainty, commercial real estate is finally entering a period of stabilization and early recovery. Analysts across Colliers, Cushman & Wakefield, CoStar, KBW, and Deloitte agree that 2026 brings a “new equilibrium,” with capital markets waking up, vacancies peaking, and investment activity returning. Office, industrial, retail, multifamily, and data center sectors each tell a different story—some recovering, some booming, some transforming—but all show signs of renewed momentum. For investors and professionals, 2026 offers cautious yet promising opportunities as the industry regains its footing.
Florida kicked off the new year with five impactful laws now in effect, influencing healthcare, insurance, animal welfare, and government employees statewide. From faster medical refund requirements to new pet‑insurance transparency rules and expanded benefits for state workers, these updates are already reshaping daily life and professional practices. Whether you work in real estate, insurance, healthcare, or any state‑licensed field, staying informed on these changes is essential as regulations continue to shift rapidly across Florida.
The commercial real estate market is entering 2026 with renewed momentum and long‑awaited signs of stability. Major research firms report a “new equilibrium” forming across asset classes, supported by lower interest rates, easing lending conditions, and returning investor confidence. Office vacancies are projected to improve, industrial demand remains strong despite reduced construction, and data centers continue to dominate growth. With capital markets reawakening and REITs poised for a potential breakout year, professionals who stay informed and expand their skill sets could find 2026 filled with fresh opportunity.
Mortgage rates have fallen to their lowest point since 2024, giving homebuyers a much‑needed break as 2026 begins. The average 30‑year fixed rate now sits near 6.12% to 6.15%, driven by multiple Fed rate cuts and cooling economic signals. While lower rates are boosting buyer optimism, tight inventory and the lingering lock‑in effect continue to challenge the market. This shift may open a key opportunity window for buyers— and for real estate and mortgage professionals looking to stay ahead of rapid industry changes.
Florida is gearing up for what could be its biggest property tax transformation in decades. With state leaders, including Gov. Ron DeSantis, exploring ways to reduce or even eliminate property taxes as early as 2026, homeowners and real estate professionals are bracing for major changes. While supporters argue that Florida can cut back the nearly $60 billion in annual property tax revenue without harming essential services, local officials warn the move could jeopardize police, fire, EMS, and community programs. As the debate intensifies heading into the 2026 legislative session, the future of Florida’s housing affordability and municipal funding hangs in the balance.
Florida is starting 2026 with a slate of major new laws impacting health care, insurance, real estate, consumer protection, and public safety. From free breast‑cancer diagnostic exams for state employees to new transparency rules for condo associations and stricter regulations on pet insurance, these changes will influence professionals across multiple industries. Whether you work in real estate, insurance, health services, or public policy, understanding these updates will help you stay compliant and ahead of Florida’s fast‑evolving regulatory landscape.
